Lungpacer Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 42

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $20M

  • Investors
  • 15

Lungpacer General Information

Description

Manufacturer of therapy devices intended for the treatment of diaphragm muscle in critically ill patients who require mechanical ventilation. The company's diaphragm therapy system uses the body's nervous system to send messages to the diaphragm muscle to the source of natural breathing and provides repetitive exercises to rebuild diaphragm muscle strength critical to healthy breathing, enabling patients to prevent and reverse muscle-disuse atrophy and maintain diaphragmatic endurance.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 601 West Cordova Street
  • Suite 130
  • Vancouver, British Columbia V6B 1G1
  • Canada
+1 (778)
Primary Industry
Therapeutic Devices
Other Industries
Diagnostic Equipment
Monitoring Equipment
Vertical(s)
Corporate Office
  • 601 West Cordova Street
  • Suite 130
  • Vancouver, British Columbia V6B 1G1
  • Canada
+1 (778)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lungpacer Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Later Stage VC (Series B) 06-Apr-2022 $20M Completed Clinical Trials - General
12. Later Stage VC (Series B) 22-Dec-2020 Completed Clinical Trials - General
11. Later Stage VC (Series 2) 07-Aug-2019 Completed Clinical Trials - General
10. Later Stage VC (Series B) 30-Apr-2019 Completed Clinical Trials - General
9. Accelerator/Incubator 01-Jun-2018 Completed Clinical Trials - General
8. Later Stage VC 01-Jan-2018 Completed Clinical Trials - General
7. Later Stage VC (Series A) 27-Apr-2017 Completed Clinical Trials - General
6. Accelerator/Incubator 26-Nov-2013 Completed Startup
5. Grant 28-Mar-2013 $160K $245K Completed Startup
4. Grant 14-Apr-2010 $170K $245K Completed Startup
To view Lungpacer’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Lungpacer Patents

Lungpacer Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230023475-A1 Systems and methods for stimulation Pending 13-Jan-2020
EP-4090413-A1 Systems and methods for stimulation Pending 13-Jan-2020
EP-4090413-A4 Systems and methods for stimulation Pending 13-Jan-2020
US-20200391027-A1 Circuitry for medical stimulation systems Active 12-Jun-2019
EP-3983057-A4 Circuitry for medical stimulation systems Pending 12-Jun-2019 A61N1/3601
To view Lungpacer’s complete patent history, request access »

Lungpacer Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lungpacer Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
WJFS Family Office Minority
4CGE Venture Capital Minority
KCK MedTech Venture Capital Minority
New Enterprise Associates Venture Capital Minority
MedTech Innovator Accelerator/Incubator Minority
You’re viewing 5 of 15 investors. Get the full list »

Lungpacer FAQs

  • When was Lungpacer founded?

    Lungpacer was founded in 2009.

  • Where is Lungpacer headquartered?

    Lungpacer is headquartered in Vancouver, Canada.

  • What is the size of Lungpacer?

    Lungpacer has 42 total employees.

  • What industry is Lungpacer in?

    Lungpacer’s primary industry is Therapeutic Devices.

  • Is Lungpacer a private or public company?

    Lungpacer is a Private company.

  • What is Lungpacer’s current revenue?

    The current revenue for Lungpacer is .

  • How much funding has Lungpacer raised over time?

    Lungpacer has raised $205M.

  • Who are Lungpacer’s investors?

    WJFS, 4CGE, KCK MedTech, New Enterprise Associates, and MedTech Innovator are 5 of 15 investors who have invested in Lungpacer.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »